Imaginostics

About:

Imaginostics is creating the next generation of precision medicine diagnostic tools.

Website: https://imaginostics.com/

Top Investors: National Institute on Aging, Alzheimer's Drug Discovery Foundation, National Institute of Mental Health, Ideaship, UB Ventures LLC

Description:

Imaginostics is creating the next generation of precision medicine diagnostic tools to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and fight aging. Our proprietary MRI physics-based technology delivers 10X better vascular images and quantitative measurements for vascular structure, function, and leakage. Our technology and software are compatible with existing MRI scanners, and as a bonus, is compatible with safe iron supplement for contrast (not toxic gadolinium). We provide biomarker solutions through CROs to pharma and participate in pre-clinical and clinical research in a variety of focus areas collaborating with world-renowned researchers at leading institutions. To learn more, please visit: http://www.imaginostics.com

Total Funding Amount:

$3.13M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Orlando, Florida, United States

Founded Date:

2018-07-10

Contact Email:

info(AT)imaginostics.com

Founders:

Codi Gharagouzloo, Valerie Gharagouzloo

Number of Employees:

1-10

Last Funding Date:

2022-09-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai